RIGI and neuroblastoma: The DNMT inhibitor 5-aza-2′-deoxycytidine was identified to induce a retinoic acid-inducible gene I (RIG-I/DDX58)-related innate immune response, one of most significant anti-dsRNA virus immune signalling pathways, by modulating mitochondrial stress in neuroblastoma [15].